We are initiating coverage of BOLDFACE Group, Inc. with a Speculative Buy Rating and $1.50 target price on 87.4MM million shares fully diluted and 5 X DPV of 2015 NBT revenue forecast of @$40 million.
...
Initiating Coverage of BOLDFACE Group, Inc. with $1.50 Short Term Target
Our celebrity beauty licensing company Boldface Group announced this week that CVS/pharmacy® has expanded the Beauty Brand's presence to 2100 key beauty doors after a successful initial launch of the Company's limited edition Holiday line.
CVS is one of the KEY retail stores for cosmetics in United States—it’s the store that launched Selma Hayek’s Nuance $100 million cosmetic line—they CLEARLY know how to sell celebrity cosmetics to their customer.
Then…for some unknown reason—somebody DUMPED stock on the announcement—heh?
Boldface will showcase the Company's newly launching Khroma products in standalone display unites strategically placed in the beauty areas at CVS/pharmacy® stores as of March 2013 .
The full launch assortment by Kourtney, Kim and Khloe includes four unique mascara offerings, Joystick long lasting moisturizing lipstick and Honey Sticks wild honey flavored lip gloss. All products bring a luxury feel and quality to the mass customer, with exquisite formulas to emulate the eyes, lips and complexion looks for which the Kardashians are famous.
With average sell though of 75% and sales per CVS store an estimated $4800 at wholesale price…this figures to be a $million dollar account for Boldface…and bear in mind there are 9500 total CVS stores in the United States.
Job well done!
Founder and Editor-in-Chief for NBTEquitiesResearch.com. Contributor and Anchor for the Fox News Channel and Fox Business Network 2000-2013. Chairman & CEO of NBT Group, Inc., a boutique private capital investment bank and investor relations organization.
- Login to post comments
